Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
LLYEli Lilly And Co Live data
$1,184.78▲ +1.32 (0.1%%)as of Sep 29, 2026, 1:54 AM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$716.08$1,292.65
Daily Price Range
Day up 0.1%%
$1,172.56$1,194.09
Volume
vs 2M avg
2M2M avg
Profile
Identity and capital structure
SectorEquity
IndustryCommon Stock
Market Cap$1.12T
Short % of Float—
Employees—
Sales—
Shares Outstanding945,323,182
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepageinvestor.lilly.com
Eli Lilly And Co — Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the sec….· via yahoo
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for LLY.
Price targets unavailable — no 12-month targets on file for LLY.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on LLY, calculate Margin of Safety, and stress-test WACC discount hurdles.
Data as ofQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedSep 29, 2026, 1:54 AM UTC